Stocks and Investing
Stocks and Investing
Tue, April 2, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, April 1, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tiago Fauth Maintained (AVTE) at Buy and Held Target at $35 on, Apr 1st, 2024
Tiago Fauth of Wells Fargo, Maintained "Aerovate Therapeutics, Inc." (AVTE) at Buy and Held Target at $35 on, Apr 1st, 2024.
Tiago has made no other calls on AVTE in the last 4 months.
There is 1 other peer that has a rating on AVTE. Out of the 1 peers that are also analyzing AVTE, 0 agree with Tiago's Rating of Hold.
This is the rating of the analyst that currently disagrees with Tiago
- Eun Yang of "Jefferies" Initiated at Strong Buy with Increased Target to $65 on, Monday, March 25th, 2024
Contributing Sources